* Oscar Health Inc OSCR.N reported a quarterly adjusted
loss
of 66 cents per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of $-1.05. The mean expectation of four analysts
for the quarter was for a loss of 72 cents per share. Wall
Street expected results to range from -74 cents to -69 cents per
share.
* Revenue rose 43.9% to $1.43 billion from a year ago;
analysts
expected $1.42 billion.
* Oscar Health Inc's reported EPS for the quarter was a loss
of 66
cents.
* The company reported a quarterly loss of $150.03 million.
* Oscar Health Inc shares had risen by 48.5% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 1.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the life & health
insurance peer group is also "buy"
Wall Street's median 12-month price target for Oscar Health Inc
is $10.00
This summary was machine generated from LSEG data February 7 at
11:37 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.72 -0.66 Beat
Sep. 30 2023 -0.47 -0.29 Beat
Jun. 30 2023 -0.23 -0.07 Beat
Mar. 31 2023 -0.05 -0.18 Missed